Narayan, H. K., Putt, M. E., Kosaraju, N., Paz, A., Bhatt, S., Plappert, T., . . . Ky, B. Dexrazoxane preferentially mitigates doxorubicin cardiotoxicity in female children with sarcoma. BMJ Publishing Group.
Chicago Style (17th ed.) CitationNarayan, Hari K., et al. Dexrazoxane Preferentially Mitigates Doxorubicin Cardiotoxicity in Female Children with Sarcoma. BMJ Publishing Group.
MLA (9th ed.) CitationNarayan, Hari K., et al. Dexrazoxane Preferentially Mitigates Doxorubicin Cardiotoxicity in Female Children with Sarcoma. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.